These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

26 related articles for article (PubMed ID: 28250343)

  • 1. Development, optimization, and evaluation of PEGylated brucine-loaded PLGA nanoparticles.
    Elsewedy HS; Dhubiab BEA; Mahdy MA; Elnahas HM
    Drug Deliv; 2020 Dec; 27(1):1134-1146. PubMed ID: 32729331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering of a novel adjuvant based on lipid-polymer hybrid nanoparticles: A quality-by-design approach.
    Rose F; Wern JE; Ingvarsson PT; van de Weert M; Andersen P; Follmann F; Foged C
    J Control Release; 2015 Jul; 210():48-57. PubMed ID: 25957906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Definition of formulation design space, in vitro bioactivity and in vivo biodistribution for hydrophilic drug loaded PLGA/PEO-PPO-PEO nanoparticles using OFAT experiments.
    Simonoska Crcarevska M; Geskovski N; Calis S; Dimchevska S; Kuzmanovska S; Petruševski G; Kajdžanoska M; Ugarkovic S; Goracinova K
    Eur J Pharm Sci; 2013 Apr; 49(1):65-80. PubMed ID: 23439240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and optimization of NSAID loaded nanoparticles.
    Sashmal S; Mukherjee S; Ray S; Thakur RS; Ghosh LK; Gupta BK
    Pak J Pharm Sci; 2007 Apr; 20(2):157-62. PubMed ID: 17416573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Method for Preparing Surface-Modified Fluocinolone Acetonide Loaded PLGA Nanoparticles for Ocular Use: In Vitro and In Vivo Evaluations.
    Salama AH; Mahmoud AA; Kamel R
    AAPS PharmSciTech; 2016 Oct; 17(5):1159-72. PubMed ID: 26589410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High loading efficiency and sustained release of siRNA encapsulated in PLGA nanoparticles: quality by design optimization and characterization.
    Cun D; Jensen DK; Maltesen MJ; Bunker M; Whiteside P; Scurr D; Foged C; Nielsen HM
    Eur J Pharm Biopharm; 2011 Jan; 77(1):26-35. PubMed ID: 21093589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the Properties of Poly(lactic-co-glycolic acid) Nanoparticle Formulations Encapsulating a Hydrophobic Drug by Using the Quality by Design Approach.
    Kozaki M; Kobayashi SI; Goda Y; Okuda H; Sakai-Kato K
    Chem Pharm Bull (Tokyo); 2017; 65(3):218-228. PubMed ID: 28250343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of nanoparticle properties, detection method, delivery route and animal model on poly(lactic-co-glycolic) acid nanoparticles biodistribution in mice and rats.
    Simon LC; Sabliov CM
    Drug Metab Rev; 2014 May; 46(2):128-41. PubMed ID: 24303927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Quality by Design Approach to Developing and Manufacturing Polymeric Nanoparticle Drug Products.
    Troiano G; Nolan J; Parsons D; Van Geen Hoven C; Zale S
    AAPS J; 2016 Nov; 18(6):1354-1365. PubMed ID: 27631558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of experiments (DoE) in pharmaceutical development.
    N Politis S; Colombo P; Colombo G; M Rekkas D
    Drug Dev Ind Pharm; 2017 Jun; 43(6):889-901. PubMed ID: 28166428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality by Design Applied to Ocular Solid Lipid Nanoparticles Containing a Hydrophilic Peptide Prepared via Hot High Pressure Homogeniser.
    Mercuri AM
    Curr Drug Deliv; 2016; 13(8):1247-1260. PubMed ID: 27012669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality by design (QbD) approach in processing polymeric nanoparticles loading anticancer drugs by high pressure homogenizer.
    Soni G; Kale K; Shetty S; Gupta MK; Yadav KS
    Heliyon; 2020 Apr; 6(4):e03846. PubMed ID: 32373744
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.